E7449 is a novel, potent inhibitor of the DNA repair proteins PARP1 and 2; it traps PARP onto DNA to augment cytotoxicity and, comparable to earlier PARP inhibitors it exhibits selectivity for tumor cells that are deficient in HR repair and other DNA repair pathway proteins. The gene discussed is XRCC6P5; the disease is neoplasm.